Department of Nephrology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Department of General Medicine, Changqing Chaoming Community Health Service Center, Red Cross Hospital of Xiachen, Hangzhou, Zhejiang, People's Republic of China.
J Cell Biochem. 2019 Sep;120(9):16273-16282. doi: 10.1002/jcb.28909. Epub 2019 May 14.
Acute kidney injury (AKI) is a common kidney disorder that affects public health and the incidence of AKI. Sepsis, acute ischemia or hypoxia is the main reason for the occurrence of AKI. Recently, noncoding RNA that include microRNA and long noncoding RNA (lncRNAs) were reported to play important roles in AKI as well as have the potential to serve as a biomarker or therapeutic target for the development of the diagnostic and prognostic strategies of AKI. In the current study, we aimed to investigate the expression and biological function of lncRNA nuclear enriched abundant transcript 1 (NEAT1) in ischemia-induced AKI in patients' sample and in vitro. The expressions of NEAT1 and miR-27a-3p in ischemia/reperfusion-induced AKI patients were examined by quantitative reverse transcription polymerase chain reaction. Cell injury was induced by treatment of human kidney tubular cells (HK-2) with CoCl . After treatment, the influences of NEAT1 and miR-27a-3p on the cell apoptosis in the CoCl -stimulated HK-2 were tested by flow cytometry. The flow analysis results showed that the expression of NEAT1 was markedly higher in the ischemia-induced AKI patients compared with normal control. Moreover, repression the expression of NEAT1 decreased CoCl -induced injury in HK-2. The expression of miR-27a-3p was negatively regulated by NEAT1. Inhibition the expression of NEAT1 attenuated overexpression of miR-27a-3p enhanced CoCl -induced injury. In summary, an ischemia-induced injury may be enhanced by a high level of NEAT1 through targeting miR-27a-3p. Thus, NEAT1 has the potential to be explored as a biomarker for diagnosis and target for therapeutic strategies in ischemia-induced AKI.
急性肾损伤(AKI)是一种常见的肾脏疾病,影响公众健康和 AKI 的发病率。脓毒症、急性缺血或缺氧是 AKI 发生的主要原因。最近,非编码 RNA,包括 microRNA 和长非编码 RNA(lncRNA),被报道在 AKI 中发挥重要作用,并有可能作为 AKI 的诊断和预后策略的生物标志物或治疗靶点。在本研究中,我们旨在研究 lncRNA 核富集丰富转录本 1(NEAT1)在患者样本和体外缺血诱导的 AKI 中的表达和生物学功能。通过定量逆转录聚合酶链反应检测缺血/再灌注诱导的 AKI 患者中 NEAT1 和 miR-27a-3p 的表达。用 CoCl 处理人肾小管细胞(HK-2)诱导细胞损伤。处理后,通过流式细胞术检测 NEAT1 和 miR-27a-3p 对 CoCl 刺激的 HK-2 细胞凋亡的影响。流式分析结果表明,与正常对照组相比,缺血诱导的 AKI 患者中 NEAT1 的表达明显升高。此外,抑制 NEAT1 的表达可降低 CoCl 诱导的 HK-2 损伤。miR-27a-3p 的表达受 NEAT1 负调控。抑制 NEAT1 的表达可减弱过表达 miR-27a-3p 增强的 CoCl 诱导的损伤。总之,高水平的 NEAT1 可能通过靶向 miR-27a-3p 增强缺血诱导的损伤。因此,NEAT1 有可能作为缺血性 AKI 的诊断标志物和治疗靶点进行探索。